Journal:
:iranian red crescent medical journal
0
saam noroozi neurology research center, kerman university of medical sciences, kerman, iran; department of biochemistry, school of medicine, kerman university of medical sciences, kerman, iran
mohammad kazemi arababadi immunology of infectious diseases research center, rafsanjan university of medical sciences, rafsanjan, iran; department of laboratory sciences, faculty of paramedicine, rafsanjan university of medical sciences, rafsanjan, iran
hossein ali ebrahimi meimand neurology research center, kerman university of medical sciences, kerman, iran
gholamreza asadikaram department of biochemistry, school of medicine, kerman university of medical sciences, kerman, iran; neuroscience research center, institute of neuropharmacology, kerman university of medical sciences, kerman, iran; endocrinology and metabolism research center, institute of basic and clinical physiology sciences, kerman, iran; endocrinology and metabolism research center, institute of basic and clinical physiology sciences, kerman, iran. tel: +98-9131406916, fax: +98-3413222048
conclusions this study showed that ifnβ-1a decreased oxidant impacts in ms patients, but had no influence in improving mitochondrial dysfunction. results in the patients group (30 patients), a significant difference was observed in their measured biochemical factors in comparison to the control group (p = 0.001), however, after six months of using ifnβ-1a, only mda was shown in the main (p = 0....